Gradient Ventures and Workday Ventures were part of Flatfile’s $50m series B round while KPN Ventures is set to exit ZecOps through an acquisition.
Tata Digital provided $200m for BigBasket while Convivialité Ventures took part in an $80m series B round for Not So Dark.
FTX-backed PayUp agreed to merge with IG Acquisition while multiple corporates participated in Line Man Wongnai’s $265m series B round.
RxCelerate took part in Rivus Pharmaceuticals’ $132m series B round while Bank of America and Citi backed AccessFintech’s $60m series C.
Beauty treatments, medical procedures and personalisation are blending together, with China at the forefront of these key trends.
Brevan Howard Digital has led a $35m series B round for Messari while Robert Bosch Venture Capital participated in Tulu’s $25m series A.
Novo Holdings led a $75m series C round for Kate Farms while PayU and InfoEdge Ventures participated in DotPe’s $58m series B.
Alphabet led a $1bn round for its life sciences unit, PTT bets on insect startup and corporate-backed Propzy is set to shut down.
Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.
Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
